50 related articles for article (PubMed ID: 11729359)
1. Effect of Benifuuki Tea on Cytochrome P450-mediated Metabolic Activity in Rats.
Hirai T; Nishimura Y; Kurata N; Namba H; Iwase M; Gomi Y; Tsuchiya H; Yamakawa T; Kiuchi Y
In Vivo; 2018; 32(1):33-40. PubMed ID: 29275296
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of phenobarbital-induced cytochrome P450 expression in carbon tetrachloride-induced hepatitis in mice models.
Fujino C; Kuzu T; Kubo Y; Hayashi K; Ueshima S; Katsura T
Biopharm Drug Dispos; 2023 Oct; 44(5):351-357. PubMed ID: 37032489
[TBL] [Abstract][Full Text] [Related]
3.
Tareen MU; Riaz S; Malik SS; Zahid S; Khursheed A; Tariq F; Abbas F; Malik MN; Anis RA; Anees M; Murtaza I; Sultan A
Exp Biol Med (Maywood); 2023 Sep; 248(17):1507-1517. PubMed ID: 37688505
[TBL] [Abstract][Full Text] [Related]
4. Global liver proteomics of rats exposed for 5 days to phenobarbital identifies changes associated with cancer and with CYP metabolism.
Dail MB; Shack LA; Chambers JE; Burgess SC
Toxicol Sci; 2008 Dec; 106(2):556-69. PubMed ID: 18796496
[TBL] [Abstract][Full Text] [Related]
5. An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen.
Andersen TT; Georgekutty J; Defreest LA; Amaratunga G; Narendran A; Lemanski N; Jacobson HI; Bennett JA
Br J Cancer; 2007 Aug; 97(3):327-33. PubMed ID: 17637684
[TBL] [Abstract][Full Text] [Related]
6. Differences of Atomic-Level Interactions between Midazolam and Two CYP Isoforms 3A4 and 3A5.
Liu S; Zheng Q; Bai F
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836743
[TBL] [Abstract][Full Text] [Related]
7. Chlorogenic acid abates oxido-inflammatory and apoptotic responses in the liver and kidney of Tamoxifen-treated rats.
E Owumi S; K Olusola J; O Arunsi U; K Oyelere A
Toxicol Res (Camb); 2021 Mar; 10(2):345-353. PubMed ID: 33884184
[TBL] [Abstract][Full Text] [Related]
8. Normal variation of the gut microbiota affects hepatic cytochrome P450 activity in mice.
Togao M; Tajima S; Kurakawa T; Wagai G; Otsuka J; Kado S; Kawakami K
Pharmacol Res Perspect; 2021 Dec; 9(6):e00893. PubMed ID: 34747570
[TBL] [Abstract][Full Text] [Related]
9. Age-related modifications in CYP-dependent drug metabolism: role of stress.
Konstandi M; Johnson EO
Front Endocrinol (Lausanne); 2023; 14():1143835. PubMed ID: 37293497
[TBL] [Abstract][Full Text] [Related]
10. Induction and repression effects on CYP and transporter protein abundance by azole mixture uptake in rat liver.
Hammer H; Schmidt F; Heise T; Knebel C; Dabrowski A; Planatscher H; Kneuer C; Marx-Stoelting P; Pötz O
EXCLI J; 2020; 19():904-916. PubMed ID: 33343269
[TBL] [Abstract][Full Text] [Related]
11. REMOVED: Glutathione prevents cytochrome P450 3A induction by dexamethasone in primary cultures of rat hepatocytes.
Richert L; Binda D; Alexandre E; Bars R; Martin H; Lasserre-Bigot D
Toxicol In Vitro; 2006 Aug; ():. PubMed ID: 16978831
[TBL] [Abstract][Full Text] [Related]
12. Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.
Hertz DL; Barlow WE; Kidwell KM; Albain KS; Vandenberg TA; Dakhil SR; Tirumali NR; Livingston RB; Gralow J; Hayes DF; Hortobagyi GN; Mehta RS; Rae JM
Br J Clin Pharmacol; 2016 Jun; 81(6):1134-41. PubMed ID: 26859101
[TBL] [Abstract][Full Text] [Related]
13. Targeting tamoxifen to breast cancer xenograft tumours: preclinical efficacy of folate-attached nanoparticles based on alginate-cysteine/disulphide-bond-reduced albumin.
Martínez A; Muñiz E; Teijón C; Iglesias I; Teijón JM; Blanco MD
Pharm Res; 2014 May; 31(5):1264-74. PubMed ID: 24218224
[TBL] [Abstract][Full Text] [Related]
14. Interactions between antiretrovirals and antineoplastic drug therapy.
Antoniou T; Tseng AL
Clin Pharmacokinet; 2005; 44(2):111-45. PubMed ID: 15656694
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of cytochromes P450 2B in rat liver by orphenadrine.
Murray M; Fiala-Beer E; Sutton D
Br J Pharmacol; 2003 Jun; 139(4):787-96. PubMed ID: 12813002
[TBL] [Abstract][Full Text] [Related]
16. Molecular and pharmacokinetic evaluation of rat hepatic and gastrointestinal cytochrome p450 induction by tamoxifen.
Cotreau MM; von Moltke LL; Harmatz JS; Greenblatt DJ
Pharmacology; 2001; 63(4):210-9. PubMed ID: 11729359
[TBL] [Abstract][Full Text] [Related]
17. Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level.
Cotreau MM; von Moltke LL; Beinfeld MC; Greenblatt DJ
J Pharmacol Toxicol Methods; 2000; 43(1):41-54. PubMed ID: 11091129
[TBL] [Abstract][Full Text] [Related]
18. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy.
Dehal SS; Brodie AM; Kupfer D
Drug Metab Dispos; 1999 Mar; 27(3):389-94. PubMed ID: 10064571
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
